Tumor circulating DNA KRAS mutation detection method
A technology for tumor patients and tumor cells, applied in the direction of DNA/RNA fragments, recombinant DNA technology, biochemical equipment and methods, etc., can solve the problem of insufficient sensitivity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0050] The SEQ ID NO:1-4 of the present invention was synthesized by Sangon Bioengineering (Shanghai) Co., Ltd.
Embodiment 2
[0052] The second exon of KRAS in 18 colorectal cancer tissues and paired circulating DNA was sequenced on the ABI 3730 sequencer. We collected frozen tissues of 18 cases of colorectal cancer operated in 2014 and extracted tissue DNA; extracted peripheral blood from patients, separated plasma, and extracted circulating DNA from tumors. The detection product of SEQ ID NO: 5 was obtained by primers 1 and 2 (PCR reaction conditions: 95°C for 15min; 94°C for 30s, 62°C for 30s, 72°C for 30s, 12 rounds, each round -0.5°C; 94°C for 30s, 56°C for 30s, 72°C for 30s, 28 rounds; 72°C for 7min, 4°C∞). The PCR products were purified, sequenced on the ABI 3730 sequencer, and the sequencing results were compared.
[0053] We found mutations in 8 samples in tumor tissue and 3 mutations in circulating DNA. The overall consistency rate of the two reached 83.3%, the positive sample consistency rate was 37.5%, and the correlation coefficient was 0.5 (Table 1).
[0054] Table 1: Comparison of t...
Embodiment 3
[0058] Using the same sample as in Example 2, obtain SEQ ID NO: 5 through primers 3 and 4, detect the product by electrophoresis, use AMPure XP beads (magnetic beads) to purify, and use PicoGreen fluorescent dye for accurate DNA quantification; add index linker: Index Kit-PCR primers (FC-121-1012, FC-121-1011), perform a second PCR reaction, and then use AMPure XP beads (magnetic beads) to purify again, use PicoGreen fluorescent dye for accurate DNA quantification, dilute to 0.015nM, 1ul sample loading. The MiSeq sequencer performs high-depth sequencing of PCR products; and performs data results.
[0059] We found that there were 8 cases of mutations in tumor tissue and 7 cases of mutations in circulating DNA, the overall agreement rate of the two was 94.4%, the agreement rate of positive samples was 87.5%, and the correlation coefficient was 0.892 (Table 2).
[0060] Table 2: Comparison of tumor tissue and circulating DNA results based on next-generation sequencing
[0061...
PUM

Abstract
Description
Claims
Application Information

- R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com